Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Allen

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 20, 2010
3-D-QSAR and docking studies on the neuronal choline transporterWerner J Geldenhuys, David D Allen, Paul R Lockman
American Journal of Pharmaceutical Education|December 7, 2006
Interdisciplinary healthcare education: fact or fiction?David D Allen, Mark A Penn, Lois Margaret Nora
American Journal of Pharmaceutical Education|December 7, 2006
Predictors of academic success in a doctor of pharmacy programKenneth L McCall, David D Allen, David S Fike
Expert Opinion on Drug Metabolism & Toxicology|April 4, 2012
Novel models for assessing blood-brain barrier drug permeationWerner J Geldenhuys, David D Allen, Jeffrey R Bloomquist
Innovations in Pharmacy|June 8, 2026
Academic conference posters: A systematic reviewMichael J Peeters, Wade Lee-Smith, David D Allen, et al.
Neurochemical Research|January 28, 2005
Cation transport specificity at the blood-brain barrierPaul R Lockman, James H McAfee, Werner J Geldenhuys, et al.
Pharmaceutical Research|December 10, 2003
In situ blood-brain barrier transport of nanoparticlesJoanna M Koziara, Paul R Lockman, David D Allen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 24, 2004
Paclitaxel nanoparticles for the potential treatment of brain tumorsJoanna M Koziara, Paul R Lockman, David D Allen, et al.
Journal of Drug Targeting|December 29, 2004
Nanoparticle surface charges alter blood-brain barrier integrity and permeabilityPaul R Lockman, Joanna M Koziara, Russell J Mumper, et al.
American Journal of Pharmaceutical Education|August 25, 2012
Report of the 2011-2012 Standing Committee On Advocacy: the relevance of excellent research: strategies for impacting public policyDavid D Allen, Julie Lauffenburger, Anandi V Law, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|July 20, 2010
3-D-QSAR and docking studies on the neuronal choline transporterWerner J Geldenhuys, David D Allen, Paul R Lockman
American Journal of Pharmaceutical Education|December 7, 2006
Interdisciplinary healthcare education: fact or fiction?David D Allen, Mark A Penn, Lois Margaret Nora
American Journal of Pharmaceutical Education|December 7, 2006
Predictors of academic success in a doctor of pharmacy programKenneth L McCall, David D Allen, David S Fike
Expert Opinion on Drug Metabolism & Toxicology|April 4, 2012
Novel models for assessing blood-brain barrier drug permeationWerner J Geldenhuys, David D Allen, Jeffrey R Bloomquist
Innovations in Pharmacy|June 8, 2026
Academic conference posters: A systematic reviewMichael J Peeters, Wade Lee-Smith, David D Allen, et al.
Neurochemical Research|January 28, 2005
Cation transport specificity at the blood-brain barrierPaul R Lockman, James H McAfee, Werner J Geldenhuys, et al.
Pharmaceutical Research|December 10, 2003
In situ blood-brain barrier transport of nanoparticlesJoanna M Koziara, Paul R Lockman, David D Allen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 24, 2004
Paclitaxel nanoparticles for the potential treatment of brain tumorsJoanna M Koziara, Paul R Lockman, David D Allen, et al.
Journal of Drug Targeting|December 29, 2004
Nanoparticle surface charges alter blood-brain barrier integrity and permeabilityPaul R Lockman, Joanna M Koziara, Russell J Mumper, et al.
American Journal of Pharmaceutical Education|August 25, 2012
Report of the 2011-2012 Standing Committee On Advocacy: the relevance of excellent research: strategies for impacting public policyDavid D Allen, Julie Lauffenburger, Anandi V Law, et al.
Pageof 6